Mylab Covid-19 antigen test kit Pathocatch gets ICMR nod, to be priced around Rs 450

The kit will be available for orders immediately and will be priced around Rs 450, it added.

Published On 2020-07-24 06:02 GMT   |   Update On 2020-07-24 06:09 GMT
Advertisement

New Delhi: Pune-based Mylab Discovery Solutions on Wednesday said it has received commercial approval from the Indian Council for Medical Research (ICMR) for its antigen testing kit for COVID-19.

The product named, ''Pathocatch COVID-19 Antigen Rapid testing kit'', is developed and manufactured in India, Mylab said in a statement.

The kit will be available for orders immediately and will be priced around Rs 450, it added.

Advertisement

The development adds another product to the company''s suite of testing solutions for COVID-19 virus, Mylab said.

"After bringing an affordable RT-PCR test to reduce dependence on foreign kits, we launched Compact XL to accelerate COVID-19 testing. Now, with the approval for an antigen testing kit, we will cover the whole spectrum of COVID-19 testing and leave no stone unturned to fight this pandemic," Mylab Discovery Solutions MD Hasmukh Rawal said.

Health experts believe that to keep up with the pace of infections, India needs a combination of both antigen and RT-PCR testing, the statement said.

Read also: Mylab unveils Compact XL To Automate Molecular Diagnostic Tests For COVID-19


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News